清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Abstract 5757: Exatecan payload-based antibody-drug conjugates with a short hydrophilic beta-glucuronidase cleavable linker

连接器 化学 结合 共价键 组合化学 生物物理学 体内 聚乙二醇 溶解度 限制 间隙 癌细胞 细胞毒性T细胞 寡肽 生物化学 细胞毒性 前药 有效载荷(计算) 聚乙二醇化 体外 毒品携带者 药品 铅化合物 卡奇霉素 娴熟的 立体化学 共轭体系
作者
Vasu Jammalamadaka,Jiang Liu,Sunil Bhakta,Vidya S. Jonnalagadda,Jagath Reddy Junutula
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:86 (7_Supplement): 5757-5757
标识
DOI:10.1158/1538-7445.am2026-5757
摘要

Abstract Antibody-drug conjugates (ADCs) enable the specific targeting of a potent cytotoxic drug to cancer cells expressing a select antigen via the release of the cytotoxin covalently linked to a target-specific antibody. A classic ADC comprises three elements: (a) a target-specific antibody that enables the binding of the ADC to cells expressing the target antigen, (b) a potent cytotoxic drug (payload) that kills cells when released from the ADC, and (c) a linker that covalently links the payload to the antibody until pre-defined conditions cause release of the payload. One of the factors limiting the in vivo biological activity of an ADC is high hydrophobicity, which stems partly from the linker or spacer and partly from the payload. In the body, high hydrophobicity often leads to aggregation of the ADC molecules; these aggregates are then rapidly cleared from circulation by the liver. Several approaches investigated in the past to reduce the overall hydrophobicity of ADCs include (a) reducing the hydrophobicity of the payload itself, (b) positioning the (hydrophobic) payload in a shielded pocket of the antibody, and (c) modifying the linker structure by introduction of hydrophilic spacers such as polyethylene glycol (PEG), polysarcosine (PSAR), hydrophilic macrocycles or long hydrophilic XTEN peptides. However, all these linker modifications involve bulky spacers, which can impact permeability into tumor tissue. Our goal was to develop short, streamlined hydrophilic linkers that boost ADC solubility without adding significant bulk. We successfully synthesized and screened several linker-payloads, and validated a novel hydrophilic, lysosomal β-glucuronidase cleavable linker combined with a short sugar-based spacer (AV-L03). We synthesized an ADC comprising trastuzumab conjugated to an exatecan payload via this novel, short, stable, hydrophilic linker AV-L03 at a drug-to-antibody ratio (DAR) of 8 and compared it to Enhertu®, which comprises trastuzumab conjugated to a DXd payload via a (hydrophobic) tetrapeptide linker. The ADC with the novel AV-L03 linker showed superior hydrophilicity, in vitro cytotoxicity, improved plasma stability, and in vivo efficacy in a mouse xenograft model compared to Enhertu®. The AV-L03 linker makes possible the use of exatecan as a payload for ADCs, which is promising given that exatecan is a more potent inhibitor of TOP1 isomerase compared to DXd, with higher permeability and bystander activity, and is a poorer substrate for some MDR pumps. Moreover, the AV-L03 linker, the shortest hydrophilic linker reported to date, is compatible with diverse payloads, and thus opens up several avenues for the design of superior ADCs. Citation Format: Vasu Jammalamadaka, Jiang Liu, Sunil Bhakta, Vidya S. Jonnalagadda, Jagath R. Junutula. Exatecan payload-based antibody-drug conjugates with a short hydrophilic beta-glucuronidase cleavable linker [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 5757.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
年轻花卷完成签到,获得积分10
3秒前
好德小饼干完成签到,获得积分20
4秒前
5秒前
饱满的醉冬完成签到 ,获得积分10
6秒前
9秒前
10秒前
魔幻萃完成签到,获得积分10
10秒前
14秒前
洁净寡妇完成签到,获得积分10
20秒前
33秒前
善良安双完成签到,获得积分10
36秒前
zhangsan完成签到,获得积分10
41秒前
温婉的乐荷完成签到,获得积分10
58秒前
从容的绿蝶完成签到,获得积分10
1分钟前
儒雅的白筠完成签到,获得积分10
1分钟前
呆萌尔风完成签到,获得积分10
1分钟前
1分钟前
灿烂而孤独的八戒完成签到 ,获得积分0
1分钟前
高高的网络完成签到,获得积分10
1分钟前
俏皮的仙人掌完成签到,获得积分10
1分钟前
景妙海完成签到 ,获得积分10
1分钟前
大方定帮完成签到,获得积分10
1分钟前
魔幻初丹完成签到,获得积分10
2分钟前
90min完成签到 ,获得积分10
2分钟前
爱思考的小笨笨完成签到,获得积分10
2分钟前
光亮的幻桃完成签到,获得积分10
2分钟前
胡萝卜完成签到,获得积分10
2分钟前
丘比特的应助被夏雪儿采纳,获得10
2分钟前
丰富的藏鸟完成签到,获得积分10
2分钟前
虚心的紫夏完成签到,获得积分10
2分钟前
2分钟前
粗心的书竹完成签到,获得积分10
2分钟前
玛卡巴卡爱吃饭完成签到 ,获得积分10
2分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
3分钟前
优秀函完成签到,获得积分10
3分钟前
朴素的荧荧完成签到,获得积分10
3分钟前
蓝意完成签到,获得积分0
3分钟前
多情莫言完成签到,获得积分10
3分钟前
null的应助被科研通管家采纳,获得10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158935
求助须知:如何正确求助?哪些是违规求助? 9554522
关于积分的说明 21719383
捐赠科研通 7748459
什么是DOI,文献DOI怎么找? 3427107
关于科研通互助平台的介绍 2552013
邀请新用户注册赠送积分活动 2471370